Results 11 to 20 of about 48,111 (219)

Usefulness of automated assays for detecting hepatitis B and C markers in dried blood spot samples

open access: yesBMC Research Notes, 2019
Objective Dried blood spots (DBSs) can be used as an alternative to serum samples because they are easily collected and can be transported without refrigeration to reference laboratories for diagnosis.
Livia Melo Villar   +6 more
doaj   +1 more source

The hidden effects of COVID-19 on HIV services in Zanzibar: country report

open access: yesAIDS Research and Therapy, 2023
The COVID-19 pandemic has had a major effect on HIV-related healthcare services. Zanzibar has experienced several interruptions of HIV services in the areas of testing and counselling, prevention of mother-to-child transmission of HIV, key population ...
Mansour Maulid Mshenga   +5 more
doaj   +1 more source

Automated quality control for a molecular surveillance system

open access: yesBMC Bioinformatics, 2018
Background Molecular surveillance and outbreak investigation are important for elimination of hepatitis C virus (HCV) infection in the United States. A web-based system, Global Hepatitis Outbreak and Surveillance Technology (GHOST), has been developed ...
Seth Sims   +10 more
doaj   +1 more source

Identification of recent cases of hepatitis C virus infection using physical-chemical properties of hypervariable region 1 and a radial basis function neural network classifier

open access: yesBMC Genomics, 2017
Background Identification of acute or recent hepatitis C virus (HCV) infections is important for detecting outbreaks and devising timely public health interventions for interruption of transmission.
James Lara, Mahder Teka, Yury Khudyakov
doaj   +1 more source

P-70 HEPATITIS B IMMUNITY AMONG CHRONIC RENAL DISEASE UNDER HEMODIALYSIS

open access: yesAnnals of Hepatology, 2023
Introduction and Objectives: Hepatitis B Virus (HBV) has been a cause of acute and chronic hepatitis with progression to cirrhosis and hepatocellular carcinoma.
Alanna Calheiros Santos   +9 more
doaj   +1 more source

Hepatitis C and hepatic steatosis [PDF]

open access: yesQJM, 2010
Hepatic steatosis is commonly seen in patients with chronic hepatitis C infection, and the two together have a greater association than by chance alone. Hepatitis C virus is closely associated with lipid metabolism throughout its lifecycle. Hepatic steatosis is more common in genotype 3 infection, due to direct viral effects including through ...
J H, Patel   +3 more
openaire   +2 more sources

Hepatitis [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2001
Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV) and another 350 million individuals are chronically infected with hepatitis B virus (HBV) (1,2). Canada is estimated to have 240,000 to 300,000 HCV and 200,000 to 280,000 HBV chronic carriers (3,4).
openaire   +3 more sources

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery

open access: yesHarm Reduction Journal, 2023
Background The World Health Organization (WHO) recommends oral pre-exposure prophylaxis (PrEP) for all people at substantial risk of HIV as part of combination prevention.
Graham Shaw   +11 more
doaj   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola   +4 more
wiley   +1 more source

Best practices for engaging with affected communities: chronic hepatitis B as a case study

open access: yesInfectious Diseases of Poverty
Hepatitis B is the single most common cause of liver cancer, affecting > 250 million people worldwide (mostly in resource limited communities) and killing > 1 million people annually. The condition is marked by poor rates of diagnosis (14%) and treatment
Thomas Tu   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy